This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Investigations

Authoring team

The investigations of note in peripheral neuropathy include:

  • FBC
  • ESR, CRP
  • LFTs, GGT
  • TFTs
  • glucose
  • creatinine
  • plasma B12 and folate
  • serum protein electrophoresis and immunoelectrophoresis
  • urinalysis
  • CXR

Subsequently, EMG and peripheral nerve conduction; if these are normal and assuming symptoms and signs are confined to the legs, question whether there is a lesion in the cauda equina.

Notes:

  • other special investigations may include serum vitamin E concentrations, cryoglobulins, urinary heavy metals and porphyrins, antinuclear antibodies, rheumatoid factor, Sjogren's syndrome (SS) antibodies, (SS-A (anti-Ro) and SS-B (anti- La)), serology for Lyme disease and HIV, antiganglioside GM1 antibodies, Schirmer's test; if raised inflammatory markers and features of possible paraneoplastic peripheral neuropathy then further investigation for possible occult malignancy

Reference:

  • McLeod JG. Investigation of peripheral neuropathy. Journal of Neurology, Neurosurgery, and Psychiatry 1995;58:274-283.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.